Inactive Instrument
Intervacc AB (publ) Stock Nasdaq Stockholm
Stocks
SE0009607252
Biotechnology & Medical Research
| Market Cap | 451M 46.91M 40.99M 37.92M 35.39M 66.44M 4.43B 66.92M 175M 2.18B 176M 172M 7.57B | P/E 2026 * |
-5.51x | P/E 2027 * | -5.51x |
|---|---|---|---|---|---|
| Enterprise Value | 364M 37.85M 33.07M 30.59M 28.56M 53.61M 3.58B 54M 141M 1.76B 142M 139M 6.11B | EV / Sales 2026 * |
22.7x | EV / Sales 2027 * | 11.8x |
| Free-Float |
80.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.15% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 70 | 2026-02-04 | |
Jan Persson
DFI | Director of Finance/CFO | - | 2020-02-05 |
Andrew Waller
CTO | Chief Tech/Sci/R&D Officer | - | 2020-06-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Emil Billbäck
CHM | Chairman | 56 | 2026-05-12 |
| Director/Board Member | 72 | 2023-12-31 | |
| Director/Board Member | 68 | 2024-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.15% | -1.02% | - | - | 46.91M | |
| +2.16% | +7.54% | +74.42% | +123.79% | 56.65B | |
| -0.49% | +6.98% | +62.88% | +67.95% | 47.49B | |
| +0.72% | +1.79% | -11.56% | -14.97% | 22.81B | |
| +0.88% | +3.71% | -6.03% | +396.29% | 21.37B | |
| +1.30% | +0.71% | +29.21% | -17.51% | 16.12B | |
| +3.20% | +9.80% | +26.27% | -34.74% | 15.56B | |
| +0.17% | -0.90% | +19.05% | +159.97% | 12.91B | |
| 0.00% | +15.02% | +133.24% | +273.89% | 12.86B | |
| +1.43% | -5.06% | +23.53% | - | 11.67B | |
| Average | +0.70% | +1.74% | +39.00% | +119.33% | 24.16B | |
| Weighted average by Cap. | +1.00% | +3.17% | +45.63% | +112.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16M 1.67M 1.46M 1.35M 1.26M 2.36M 157M 2.38M 6.23M 77.4M 6.25M 6.12M 269M | 30M 3.12M 2.73M 2.52M 2.36M 4.42M 295M 4.46M 11.67M 145M 11.73M 11.47M 504M |
| Net income | -81.6M -8.5M -7.42M -6.87M -6.41M -12.03M -803M -12.12M -31.75M -395M -31.9M -31.21M -1.37B | -83.3M -8.67M -7.58M -7.01M -6.54M -12.28M -820M -12.37M -32.41M -403M -32.56M -31.86M -1.4B |
| Net Debt | -87M -9.06M -7.91M -7.32M -6.83M -12.83M -856M -12.92M -33.85M -421M -34.01M -33.27M -1.46B | -96M -10M -8.73M -8.08M -7.54M -14.16M -945M -14.26M -37.35M -464M -37.53M -36.71M -1.61B |
Employees
-
Calendar
